February 2022 PMID 35167091

Activating Human Adipose Tissue with the β3-Adrenergic Agonist Mirabegron.

Kong Y Chen, Robert J Brychta, Nikita S Israni, Alex Jiang, Hannah J Lea, Taylor N Lentz, Anne E Pierce, Aaron M Cypess

Full text PDF Download social card

Mentions

Peak: 2 in Feb 2022

across 2 sources since Feb 2022

Extended reach

5,501

potential audience

Total likes

Video views

875

Mentions per month

Feb 2022 – Apr 2025

Where it's discussed

X / Twitter2 posts
YouTube1 videos

AI synopsis

What people are saying

The analysis indicates a generally positive and moderately engaged attitude, with several posts emphasizing the innovative aspect of using a standardized oral medication to activate BAT, which could have meaningful health implications. Words such as 'promising,' 'potential,' and phrases referencing metabolic health underscore a cautiously optimistic tone, highlighting the perceived importance of the research while acknowledging it is an early step toward broader applications.

AgreementModerate agreement

The positive tone in many posts suggests general support for the research findings, with comments highlighting excited responses to BAT activation and potential health benefits.

InterestModerate interest

Posts express moderate curiosity, often mentioning the significance of activating brown adipose tissue and its clinical implications, although some show a neutral stance.

EngagementModerate engagement

Discussion includes references to the mechanisms and potential applications, indicating thoughtful reflections rather than superficial comments.

ImpactNeutral impact

The consensus seems to recognize that while the findings could influence future therapy approaches, the immediate impact on current practices remains limited.

Abstract in brief

Activation of brown adipose tissue (BAT) through the 3 adrenergic receptor agonist mirabegron offers a promising approach for treating metabolic diseases in humans.
The study highlights that BAT activation can be managed with standardized oral medication, reducing the stress associated with cold exposure methods.
Both acute and chronic use of mirabegron enhance BAT's volume and metabolic activity, as measured by PET/CT imaging, indicating potential benefits for metabolic health.

Read the full abstract

All mentions

Enhancing Fat Loss with Mirabegron and Beta-3 Receptor Activation

Mirabegron activates beige fat tissue, which may help address obesity and metabolic issues like type 2 diabetes. Recent research shows optimal dosing promotes fat beiging without harmful effects, positively impacting…

VigorousClips · Apr 7, 2025 875 views

Tom

@petctimaging · X

Activating Human Adipose Tissue with the β3-Adrenergic Agonist Mirabegron https://t.co/opPweQbtpH

Feb 18, 2022 · 2,174 followers View post →

Adipose Papers

@adipose_papers · X

Activating Human Adipose Tissue with the beta3-Adrenergic Agonist Mirabegron https://t.co/45plIYsRRT https://t.co/HHHpJgUIzx

Feb 15, 2022 · 1 like · 2,453 followers View post →